Key result
The UMOD SNP rs13333226 G allele was independently associated with a significantly increased risk of end stage renal disease in Han Chinese patients (OR 2.30).
Why the study?
Does the UMOD SNP rs13333226 G allele increase the risk of end stage renal disease in Han Chinese patients?
Case-Control (n=1,004)
Does the UMOD SNP rs13333226 G allele increase the risk of end stage renal disease in Han Chinese patients?
Effect estimate: OR 2.30 (95% CI 1.70-3.11)
Absolute Event Rate: 36.83% vs 20.22%
p-value: p=6.10×10-8
The common genetic variation rs13333226 in the promoter region of the UMOD gene is independently associated with an increased risk of end-stage renal disease in the Han Chinese population.
Several genome-wide association studies revealed that several variants of UMOD gene were related to the estimated glomerular filtration rate (eGFR), CKD or hypertension. In this study, we investigated the association between a common variant rs13333226 in the promoter region of UMOD gene and end stage renal disease (ESRD). Variant rs13333226 of UMOD gene was genotyped by using the ABI Real time TaqMan allelic discrimination assay in a case-control study including 638 unrelated patients with ESRD and 366 controls. The frequency of UMOD SNP rs13333226 GG/GA genotype was significantly higher (36.83% vs. 20.22%, P = 4.02 × 10-8) and the frequency of G allele was much higher (19.04% vs. 11.20%, P = 4.00 × 10−6) in the patients with ESRD than in the controls. The G allele was associated with an increased risk of ESRD (odds ratio 2.30, 95% confidence interval 1.70–3.11, P = 6.10 × 10−8). And G allele (odds ratio 2.33, 95% confidence interval 1.32–4.13, P = 3.65 × 10−3) was associated independently with ESRD. A common variation rs13333226 in the promoter region of UMOD gene was independently associated with ESRD in Han Chinese.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2016) conducted a case-control in End stage renal disease (n=1,004). UMOD SNP rs13333226 G allele vs. A allele was evaluated on End stage renal disease (OR 2.30, 95% CI 1.70-3.11, p=6.10×10-8). The UMOD SNP rs13333226 G allele was independently associated with a significantly increased risk of end stage renal disease in Han Chinese patients (OR 2.30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: